ATE80306T1 - Mittel zur absorptionsverbesserung von proteinen. - Google Patents

Mittel zur absorptionsverbesserung von proteinen.

Info

Publication number: ATE80306T1
Authority: AT; Austria
Prior art keywords: proteins; improving absorption; absorption; improving; hydroxylamine
Prior art date: 1985-03-06

Application number

AT86902132T

Other languages

English (en)

Inventor

Stanley Jay Sarnoff

Burton E Sobel

Original Assignee

Survival Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-06

Filing date

1986-03-06

Publication date

1992-09-15

1985-03-06 Priority claimed from US06/708,845 external-priority patent/US4661469A/en

1985-10-01 Priority claimed from US06/782,441 external-priority patent/US4772585A/en

1986-03-06 Application filed by Survival Technology filed Critical Survival Technology

1992-09-15 Application granted granted Critical

1992-09-15 Publication of ATE80306T1 publication Critical patent/ATE80306T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT86902132T 1985-03-06 1986-03-06 Mittel zur absorptionsverbesserung von proteinen. ATE80306T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US06/708,845 US4661469A (en)	1984-08-08	1985-03-06	t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A	1985-03-27	1985-03-27
US06/782,441 US4772585A (en)	1984-08-08	1985-10-01	Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en)	1985-03-06	1986-03-06	Protein absorption enhancing agents
EP86902132A EP0214281B1 (de)	1985-03-06	1986-03-06	Mittel zur absorptionsverbesserung von proteinen

Publications (1)

Publication Number	Publication Date
ATE80306T1 true ATE80306T1 (de)	1992-09-15

Family

ID=27418848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86902132T ATE80306T1 (de)	1985-03-06	1986-03-06	Mittel zur absorptionsverbesserung von proteinen.

Country Status (9)

Country	Link
EP (1)	EP0214281B1 (de)
AT (1)	ATE80306T1 (de)
AU (1)	AU593794B2 (de)
DE (1)	DE3686684T2 (de)
DK (1)	DK528386D0 (de)
FI (1)	FI864480A0 (de)
HU (1)	HUT41632A (de)
NO (1)	NO864382D0 (de)
WO (1)	WO1986005096A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839170A (en) *	1985-10-01	1989-06-13	Survival Technology, Inc.	Protein absorption enhancing agents
DE3544663A1 (de) *	1985-12-13	1987-06-19	Schering Ag	Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0199574B1 (de) *	1985-04-22	1991-10-23	Genentech, Inc.	Plasminogenaktivator-Mutante des menschlichen Gewebes, Verfahren und Zwischenprodukte dafür und diese Mutante verwendende Zusammensetzungen
FI85334C (fi) *	1985-05-28	1992-04-10	Wellcome Found	Foerfarande foer framstaellning av en vattenbaserad, vaevnadsplasminogenaktivator (t-pa) innehaollande, koncentrerad parenterad loesning.

1986
- 1986-03-06 EP EP86902132A patent/EP0214281B1/de not_active Expired - Lifetime
- 1986-03-06 DE DE8686902132T patent/DE3686684T2/de not_active Expired - Fee Related
- 1986-03-06 AU AU55811/86A patent/AU593794B2/en not_active Ceased
- 1986-03-06 AT AT86902132T patent/ATE80306T1/de not_active IP Right Cessation
- 1986-03-06 WO PCT/US1986/000475 patent/WO1986005096A1/en active IP Right Grant
- 1986-03-06 HU HU863035A patent/HUT41632A/hu unknown
- 1986-11-03 NO NO864382A patent/NO864382D0/no unknown
- 1986-11-04 FI FI864480A patent/FI864480A0/fi not_active Application Discontinuation
- 1986-11-05 DK DK528386A patent/DK528386D0/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
FI864480A (fi)	1986-11-04
EP0214281B1 (de)	1992-09-09
DK528386A (da)	1986-11-05
DE3686684D1 (de)	1992-10-15
AU5581186A (en)	1986-09-24
NO864382D0 (no)	1986-11-03
EP0214281A1 (de)	1987-03-18
NO864382L (no)	1986-03-11
AU593794B2 (en)	1990-02-22
DE3686684T2 (de)	1993-01-28
EP0214281A4 (de)	1989-03-16
HUT41632A (en)	1987-05-28
FI864480A0 (fi)	1986-11-04
WO1986005096A1 (en)	1986-09-12
DK528386D0 (da)	1986-11-05

Similar Documents

Publication	Publication Date	Title
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3685625D1 (de)	1992-07-16	Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
DE3687741D1 (de)	1993-03-25	Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
DE3682457D1 (de)	1991-12-19	Geraet zur verabreichung von medikamenten an patienten.
DK427485A (da)	1986-03-22	Blodkoagulationshaemmende proteiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DE3676601D1 (de)	1991-02-07	Mittel zur injektion von aktiviertem vitamin-d3.
JPS5231839A (en)	1977-03-10	Drug for cosmetics and permanent wave in combination
IT1067019B (it)	1985-03-12	Metodo e disposizione per misurare la concentrazione di composti di basso peso molecolare in mezzi complessi in particolare nel trattamento medicale
NO883834L (no)	1989-02-28	Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
DE3673217D1 (de)	1990-09-13	Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
ATE80306T1 (de)	1992-09-15	Mittel zur absorptionsverbesserung von proteinen.
DK325289A (da)	1989-12-30	Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE206458T1 (de)	2001-10-15	T-zellen stimulierendes protein von pestivirus
FI874273A (fi)	1988-04-02	Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
AU4721185A (en)	1986-03-07	Protein absorption enhancing agents
ATE79550T1 (de)	1992-09-15	Die proteinabsorption verbessernde stoffe.
AU2459188A (en)	1989-05-04	Anticoagulative protein pp4-x, and its preparation and use
DE68917520D1 (de)	1994-09-22	Verfahren und Systeme zur Herstellung von HIV-Antigenen.
DK222988D0 (da)	1988-04-22	Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
ATE105570T1 (de)	1994-05-15	Modifizierte menschliche anti-rh(d)-antikoerper.
DK381787A (da)	1987-07-21	Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
IT8421612A0 (it)	1984-06-26	Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
IT207181Z2 (it)	1987-12-14	Flaconcino con cannula sigillata monouso.

Legal Events

Date	Code	Title	Description
1993-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties